Xcopri Approval History
FDA Approved: Yes (First approved November 21, 2019)
Brand name: Xcopri
Generic name: cenobamate
Dosage form: Tablets
Company: SK Life Science, Inc.
Treatment for: Seizures
Xcopri (cenobamate) is an antiepileptic drug for the treatment of partial-onset seizures in adult patients.
Development History and FDA Approval Process for Xcopri
Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.